MyFinsight
Home
Blog
About
Back
Income Statement
Nuo Therapeutics, Inc. (AURX)
Nuo Therapeutics, Inc. (AURX)
source: myfinsight.com
Product
$1,691,045
(170.48%↑ Y/Y)
License
$77,941
(3.92%↑ Y/Y)
Net loss
-$277,601
(57.27%↑ Y/Y)
Revenue
$1,768,986
(152.64%↑ Y/Y)
Loss from operations
-$166,552
(74.46%↑ Y/Y)
Total other income
(expenses)
-$111,049
(-4859.92%↓ Y/Y)
Gross profit
$1,170,027
(116.33%↑ Y/Y)
Other income
$3,017
(155.68%↑ Y/Y)
Costs of sales
$598,959
(275.88%↑ Y/Y)
Total operating
expenses
$1,336,579
(12.05%↑ Y/Y)
Interest income
(expense), net
-$114,066
(-9992.97%↓ Y/Y)
Selling, general and
administrative
$1,336,579
(12.05%↑ Y/Y)
Back